| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/28/2006 | US20060216333 Methods related to the treatment of mucosal associated conditions |
| 09/28/2006 | US20060216328 Topical composition comprising a cyclofructan, a carrier and a drug |
| 09/28/2006 | US20060216327 Multilayer coating for releasing biologically-active agents and method of making |
| 09/28/2006 | US20060216325 Composition and device for in vivo cartilagerepair |
| 09/28/2006 | US20060216321 Solvent based processing technologies for making tissue/polymer composites |
| 09/28/2006 | US20060216296 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/28/2006 | US20060216268 Denaturants for sympathomimetic amine salts |
| 09/28/2006 | US20060216265 Dendrimers as molecular translocators |
| 09/28/2006 | US20060216261 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same |
| 09/28/2006 | US20060216245 Composition for local anesthesia |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | US20060216241 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; anxiety, muscle spasms |
| 09/28/2006 | US20060216240 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; sleep disorders |
| 09/28/2006 | US20060214037 Wet milling process |
| 09/28/2006 | DE102005024171A1 Verfahren und Vorrichtung zur Ultraschallverpressung einer Tablette oder einer multipartikulären Arzneiform Method and apparatus for Ultraschallverpressung a tablet or a multiparticulate pharmaceutical form |
| 09/28/2006 | DE102005013339A1 Device for simple and safe inhalation of inhalation agent, comprises unlockable and lockable interior hollow container with continuous openings and additionally a means for fixing on the clothes or to the body |
| 09/28/2006 | DE10015907B4 Verwendung multipartikulärer und multivesikulärer Zubereitungen für die Behandlung von entzündetem Gewebe And use multivesicular multiparticulate preparations for the treatment of inflamed tissue |
| 09/28/2006 | CA2814267A1 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | CA2602946A1 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | CA2602534A1 Transdermal patch |
| 09/28/2006 | CA2602525A1 Drug delivery systems for treatment of diseases or conditions |
| 09/28/2006 | CA2602423A1 Multi-ply technical composite which is breathable and moisturising, releases active constituents and promotes their absorption, and can be used as a medical aid or to make clothing or structures that come into direct contact with healthy or diseased skin |
| 09/28/2006 | CA2602392A1 Solubilized ibuprofen |
| 09/28/2006 | CA2602341A1 Nanoparticulate corticosteroid and antihistamine formulations |
| 09/28/2006 | CA2602210A1 Tablet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | CA2602209A1 Pellet-type controlled-release preparation containing cinnarizine and dimenhydrinate for combating vertigo |
| 09/28/2006 | CA2602024A1 Charged lipoprotein complexes for use in dyslipidemia treatments |
| 09/28/2006 | CA2602018A1 A transdermal topical composition and its uses |
| 09/28/2006 | CA2602017A1 A topical composition and its uses |
| 09/28/2006 | CA2602000A1 Solid oral dosage form of valopi citabine (val-mcyd) and method of preparing it |
| 09/28/2006 | CA2601795A1 Chewing gum compositions of varenicline |
| 09/28/2006 | CA2601441A1 Method and system for providing integrated medication infusion and analyte monitoring system |
| 09/28/2006 | CA2601373A1 Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
| 09/28/2006 | CA2601363A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | CA2601360A1 Sclerostin and the inhibition of wnt signaling and bone formation |
| 09/28/2006 | CA2601312A1 Injectable compositions of nanoparticulate immunosuppressive compounds |
| 09/28/2006 | CA2600533A1 Pharmaceutical composition |
| 09/28/2006 | CA2600525A1 Biomarkers for efficacy of aliskiren as a hypertensive agent |
| 09/28/2006 | CA2599018A1 Methods and systems for operating an aerosol generator |
| 09/28/2006 | CA2597688A1 Agglomerated starch compositions |
| 09/27/2006 | EP1704858A1 Propofol-containing fat emulsion preparation |
| 09/27/2006 | EP1704585A2 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| 09/27/2006 | EP1703965A1 Device, method and use for the formation of small particles |
| 09/27/2006 | EP1703943A2 Iontophoretic devices and methods |
| 09/27/2006 | EP1703938A1 Method of treatment for undesired effect following transdermal or topical drug delivery |
| 09/27/2006 | EP1703919A1 Vaginal compositions for treating infections |
| 09/27/2006 | EP1703915A2 Methods of using cgrp for cardiovascular and renal indications |
| 09/27/2006 | EP1703900A1 Controlled release ketoprofen formulation |
| 09/27/2006 | EP1703899A2 Stabilised compositions of factor vii polypeptides |
| 09/27/2006 | EP1703898A2 Ziprasidone formulations |
| 09/27/2006 | EP1703897A2 Method for producing keto-l-gulonic acid spray granules |
| 09/27/2006 | EP1703896A2 Pharmaceutical compositions comprising midazolam in a high concentration |
| 09/27/2006 | EP1703895A2 Controlled release cgrp delivery composition for cardiovascular and renal indications |
| 09/27/2006 | EP1703894A1 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery |
| 09/27/2006 | EP1703892A2 Uv light-stable semi-solid transdermal systems comprising a photosensitive active agent and an uv-absorbing component |
| 09/27/2006 | EP1481017B8 Biodegradable polymeric material for biomedical applications |
| 09/27/2006 | EP1471890B1 Pharmaceutical dosage form for mucosal delivery |
| 09/27/2006 | EP1421172B1 Artificial synapse chip interface for electronic prosthetic retina |
| 09/27/2006 | EP1404341B1 Active substance combination for medicamentous therapy of nicotine dependency |
| 09/27/2006 | EP1368008B1 Transdermal therapeutic system for the administration of the partial dopamine-d2 agonist aripiprazol |
| 09/27/2006 | EP1322293B1 Modified release formulation |
| 09/27/2006 | EP1286660B1 Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste |
| 09/27/2006 | EP1272907B1 Compliance tracking method |
| 09/27/2006 | EP1251832B1 Shell-and-core dosage form approaching zero-order drug release |
| 09/27/2006 | EP1246622B1 Novel substituted benzimidazole dosage forms and method of using same |
| 09/27/2006 | EP1232002B1 Method for the production of particles |
| 09/27/2006 | EP1180016B1 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 09/27/2006 | EP1173222B1 Conjugate having a cleavable linkage for use in a liposome |
| 09/27/2006 | EP1140196B1 pharmaceutical solutions comprising triphenylethylene antiestrogens |
| 09/27/2006 | EP1131053B1 Nanocapsules and method of production thereof |
| 09/27/2006 | EP1123088B1 Sustained-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 09/27/2006 | EP1000079B1 New formulation |
| 09/27/2006 | EP0951286B1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 09/27/2006 | CN1838964A Treatment and prevention of pulmonary conditions |
| 09/27/2006 | CN1838948A Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1838945A Novel formulation of ropinirole |
| 09/27/2006 | CN1838944A Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 09/27/2006 | CN1838943A Flupirtin injectable galenic form |
| 09/27/2006 | CN1838942A Compositions and methods for hydrophobic drug delivery |
| 09/27/2006 | CN1837229A Clarithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837225A Azithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837213A Bilobalide A derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837212A Bilobalide B derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837200A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837199A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837198A Tanshinone IIA derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1836732A Two kinds of novel angiogenesis-inhibiting medicine and its uses in preventing and treating tumour |
| 09/27/2006 | CN1836730A Intensified additive for chondroitin sulfate capsule formulation and tablet and its preparation method |
| 09/27/2006 | CN1836729A Target antibody compound for killing tumour cell and its preparation method |
| 09/27/2006 | CN1836727A Chymotrypsin-parenzyme oral ulcer preparation |
| 09/27/2006 | CN1836725A Traditional Chinese medicine composition for treating arthritis and preparing method thereof |
| 09/27/2006 | CN1836721A Chinese traditional medicine composition for treating infant anorexia and preparation and quality controlling method thereof |
| 09/27/2006 | CN1836720A Chinese medicine composition for treating arthritis or gout and preparing method thereof |
| 09/27/2006 | CN1836719A Pharmaceutical composition for treating gastritis, gastric ulcer and duodenal ulcer |
| 09/27/2006 | CN1836718A Health traditional Chinese medicine for invigorating constitution, strengthening brain and activating blood |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836714A Soft capsule for treating prostate disease and its preparation method and quality control method |
| 09/27/2006 | CN1836712A Pharmaceutical composition for treating sexual disorder and its preparation process |